235 related articles for article (PubMed ID: 21192231)
1. Effect of highly active antiretroviral therapy on biomarkers of B-lymphocyte activation and inflammation.
Regidor DL; Detels R; Breen EC; Widney DP; Jacobson LP; Palella F; Rinaldo CR; Bream JH; Martínez-Maza O
AIDS; 2011 Jan; 25(3):303-14. PubMed ID: 21192231
[TBL] [Abstract][Full Text] [Related]
2. The effect of HAART-induced HIV suppression on circulating markers of inflammation and immune activation.
Wada NI; Jacobson LP; Margolick JB; Breen EC; Macatangay B; Penugonda S; Martínez-Maza O; Bream JH
AIDS; 2015 Feb; 29(4):463-71. PubMed ID: 25630041
[TBL] [Abstract][Full Text] [Related]
3. Serum biomarkers of immune activation and subsequent risk of non-hodgkin B-cell lymphoma among HIV-infected women.
Hussain SK; Hessol NA; Levine AM; Breen EC; Anastos K; Cohen M; D'Souza G; Gustafson DR; Silver S; Martínez-Maza O
Cancer Epidemiol Biomarkers Prev; 2013 Nov; 22(11):2084-93. PubMed ID: 24045923
[TBL] [Abstract][Full Text] [Related]
4. Effects of combination chemotherapy and highly active antiretroviral therapy on immune parameters in HIV-1 associated lymphoma.
Powles T; Imami N; Nelson M; Gazzard BG; Bower M
AIDS; 2002 Mar; 16(4):531-6. PubMed ID: 11872995
[TBL] [Abstract][Full Text] [Related]
5. B-cell stimulatory cytokines and markers of immune activation are elevated several years prior to the diagnosis of systemic AIDS-associated non-Hodgkin B-cell lymphoma.
Breen EC; Hussain SK; Magpantay L; Jacobson LP; Detels R; Rabkin CS; Kaslow RA; Variakojis D; Bream JH; Rinaldo CR; Ambinder RF; Martinez-Maza O
Cancer Epidemiol Biomarkers Prev; 2011 Jul; 20(7):1303-14. PubMed ID: 21527584
[TBL] [Abstract][Full Text] [Related]
6. Immune recovery following antineoplastic chemotherapy and highly active antiretroviral therapy (HAART) in a child with HIV-1 infection previously unresponsive to HAART.
Galli L; Chiappini E; Lippi A; de Martino M
Int J Immunopathol Pharmacol; 2006; 19(4):919-22. PubMed ID: 17166413
[TBL] [Abstract][Full Text] [Related]
7. Plasma levels of soluble CD27: a simple marker to monitor immune activation during potent antiretroviral therapy in HIV-1-infected subjects.
De Milito A; Aleman S; Marenzi R; Sonnerborg A; Fuchs D; Zazzi M; Chiodi F
Clin Exp Immunol; 2002 Mar; 127(3):486-94. PubMed ID: 11966765
[TBL] [Abstract][Full Text] [Related]
8. Elevated serum soluble CD30 precedes the development of AIDS-associated non-Hodgkin's B cell lymphoma.
Breen EC; Fatahi S; Epeldegui M; Boscardin WJ; Detels R; Martínez-Maza O
Tumour Biol; 2006; 27(4):187-94. PubMed ID: 16651853
[TBL] [Abstract][Full Text] [Related]
9. CXCL13 as a Biomarker of Immune Activation During Early and Chronic HIV Infection.
Mehraj V; Ramendra R; Isnard S; Dupuy FP; Lebouché B; Costiniuk C; Thomas R; Szabo J; Baril JG; Trottier B; Coté P; LeBlanc R; Durand M; Chartrand-Lefebvre C; Kema I; Zhang Y; Finkelman M; Tremblay C; Routy JP
Front Immunol; 2019; 10():289. PubMed ID: 30846990
[No Abstract] [Full Text] [Related]
10. Serum levels of cytokines and biomarkers for inflammation and immune activation, and HIV-associated non-Hodgkin B-cell lymphoma risk.
Vendrame E; Hussain SK; Breen EC; Magpantay LI; Widney DP; Jacobson LP; Variakojis D; Knowlton ER; Bream JH; Ambinder RF; Detels R; Martínez-Maza O
Cancer Epidemiol Biomarkers Prev; 2014 Feb; 23(2):343-9. PubMed ID: 24220912
[TBL] [Abstract][Full Text] [Related]
11. The clinical epidemiology of Hodgkin lymphoma in HIV-infected patients in the highly active antiretroviral therapy (HAART) era.
Vilchez RA; Finch CJ; Jorgensen JL; Butel JS
Medicine (Baltimore); 2003 Mar; 82(2):77-81. PubMed ID: 12640183
[TBL] [Abstract][Full Text] [Related]
12. The effect of HIV infection and HAART on inflammatory biomarkers in a population-based cohort of women.
Keating SM; Golub ET; Nowicki M; Young M; Anastos K; Crystal H; Cohen MH; Zhang J; Greenblatt RM; Desai S; Wu S; Landay AL; Gange SJ; Norris PJ;
AIDS; 2011 Sep; 25(15):1823-32. PubMed ID: 21572306
[TBL] [Abstract][Full Text] [Related]
13. HIV-1 RNA, CD4 T-lymphocytes, and clinical response to highly active antiretroviral therapy.
Sterling TR; Chaisson RE; Moore RD
AIDS; 2001 Nov; 15(17):2251-7. PubMed ID: 11698698
[TBL] [Abstract][Full Text] [Related]
14. Serum levels of the homeostatic B cell chemokine, CXCL13, are elevated during HIV infection.
Widney DP; Breen EC; Boscardin WJ; Kitchen SG; Alcantar JM; Smith JB; Zack JA; Detels R; Martínez-Maza O
J Interferon Cytokine Res; 2005 Nov; 25(11):702-6. PubMed ID: 16318584
[TBL] [Abstract][Full Text] [Related]
15. Changes of lymphocyte apoptosis associated with sequential introduction of highly active antiretroviral therapy.
Wasmuth JC; Hackbarth F; Rockstroh JK; Sauerbruch T; Spengler U
HIV Med; 2003 Apr; 4(2):111-9. PubMed ID: 12702131
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the effectiveness of highly active antiretroviral therapy in persons with human immunodeficiency virus using biomarker-based equivalence of disease progression.
Jacobson LP; Li R; Phair J; Margolick JB; Rinaldo CR; Detels R; Muñoz A
Am J Epidemiol; 2002 Apr; 155(8):760-70. PubMed ID: 11943695
[TBL] [Abstract][Full Text] [Related]
17. Short communication: decreasing soluble CD30 and increasing IFN-gamma plasma levels are indicators of effective highly active antiretroviral therapy.
Sadeghi M; Süsal C; Daniel V; Naujokat C; Zimmermann R; Huth-Kühne A; Opelz G
AIDS Res Hum Retroviruses; 2007 Jul; 23(7):886-90. PubMed ID: 17678471
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory biomarkers and abacavir use in the Women's Interagency HIV Study and the Multicenter AIDS Cohort Study.
Palella FJ; Gange SJ; Benning L; Jacobson L; Kaplan RC; Landay AL; Tracy RP; Elion R
AIDS; 2010 Jul; 24(11):1657-65. PubMed ID: 20588104
[TBL] [Abstract][Full Text] [Related]
19. Effect of long-term highly active antiretroviral therapy in restoring HIV-induced abnormal B-lymphocyte function.
Jacobson MA; Khayam-Bashi H; Martin JN; Black D; Ng V
J Acquir Immune Defic Syndr; 2002 Dec; 31(5):472-7. PubMed ID: 12473834
[TBL] [Abstract][Full Text] [Related]
20. The effect of a year of highly active antiretroviral therapy on immune reconstruction and cytokines in HIV/AIDS patients.
Yao Y; Luo Y; He Y; Zheng Y; Zhang Q; Zhou H; Zeng S; Chen Z; He B; He M
AIDS Res Hum Retroviruses; 2013 Apr; 29(4):691-7. PubMed ID: 23151174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
